Frontiers in oncology

published

2023
- Vol. 13: Autolysosomal activation combined with lysosomal destabilization efficiently targets myeloid leukemia cells for cell death.
  
  Shah, Harshit R.; Stankov, Metodi; Panayotova Dimitrova, Diana; Yazdi, Amir; Budida, Ramachandramouli; Klusmann, Jan-Henning; Behrens, Georg M. N.
2022
- Vol. 12: Time is crucial in malignant tumor cases: speeding up the process of patient-specific implant creation
  
  Spalthoff, Simon; Nejati-Rad, Narin; Rahlf, Björn; Jehn, Philipp; Gellrich, Nils-Claudius; Lentge, Fritjof; Korn, Philippe
- Vol. 12: Navigating preemptive and therapeutic donor lymphocyte infusions in advanced myeloid malignancies by high-sensitivity chimerism analysis
  
  p. 867356
  
  Stadler, Michael; Venturini, Letizia; Bünting, Ivonne; Dammann, Elke; Weissinger, Eva; Schwarzer, Adrian; Schultze-Florey, Christian; Ehrlich, Steve; Markel, Dominik; Lueck, Catherina; Gladysz, Alexandra; Fröhlich, Tabea; Damrah, Nouraldin; Beutel, Gernot; Eder, Matthias; Ganser, Arnold; Hambach, Lothar
2021
- Vol. 11: Potential Roles of Acute Phase Proteins in Cancer: Why Do Cancer Cells Produce or Take Up Exogenous Acute Phase Protein Alpha1-Antitrypsin?
  
  p. 622076
  
  Janciauskiene, Sabina; Wrenger, Sabine; Günzel, Steffen; Gründing, Anna Ricarda; Golpon, Heiko André; Welte, Tobias